Na Kang’s study reported that Septin9 is a negative regulator of ARHGAP4; ARHGAP4 promotes tumor migration and epithelial–mesenchymal transition by activating the focal adhesion kinase (FAK)/Src signaling pathway (15). The gene discussed is ARHGAP4; the disease is neoplasm.